Our primary focus: improving outcomes for patients
Each patient's expectations for care, for treatments, for greater longevity are increasing exponentially. We live longer and our healthcare industries are taking on more and more responsibility for improving lives.
The entire patient care pathway
Every diagnostic instrument and utility, pharmaceuticals, or regenerative therapy we develop plays a particular role on the care pathway with an eye toward total healthcare covering prevention, diagnosis and treatment.
Widening access to healthcare
As our diagnostic and treatment technologies develop, so too does the reach of patient care. Our devices, instruments, mobile systems and our pharmaceuticals are bringing clinical support to remote communities and ever closer to the point-of-care – the hospital bedside, the emergency room, the first response.
User friendly technologies are helping increase efficiency and patient throughput, changing the economics of healthcare. Patient comfort and assurance, as well as helping the flow of medical procedures, are a big part of the general well-being of patients, and our systems are designed particularly with this in mind.
As we move forward, the new era of regenerative medicine is in sight.
Pharmaceuticals are designed to address unmet medical needs and extend treatment care for regenerative medicine.
Minimally Invasive Surgery
Contract Development and Manufacturing
Cell Culture Media
New Drug Development
Life Sciences Strategy
Visionary healthcare technologies
With an organization the size of Fujifilm and its various healthcare divisions, it seems inevitable that our focus is on the big picture: the efforts needed to make regenerative therapies a reality; the technologies needed to spread the reach of diagnostic imaging across continents and cultures; and the informatics to link it all up.